Enhanced anticancer efficacy of α-lipoic acid-loaded TPGS micelles: Synthesis, characterization, and evaluation in a 4T1 breast cancer model
BioImpacts · 13.04.2026 · 16 · 31242
DOI: 10.34172/bi.31242 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioImpacts, online erschienen am 13.04.2026. Verfasst von Aqeel Akab Sarhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction: α-Lipoic acid (ALA) is a potent antioxidant with anticancer properties, but its clinical application is limited by poor water solubility and low bioavailability. Current nanocarrier systems for ALA delivery suffer from low encapsulation efficiency, rapid drug release kinetics, and biocompatibility concerns that restrict their therapeutic potential. This study aimed to develop and evaluate ALA-loaded D-alpha-tocopheryl polyethylene glycol succinate (TPGS) micelles as an innovative nanomedicine platform to overcome existing limitations and enhance anticancer efficacy.
Methods
ALA was loaded into TPGS micelles via modified solvent evaporation method and comprehensively characterized by TEM, DLS, and FTIR examination. Drug loading and encapsulation efficiency were quantitatively determined. In vitro drug release kinetics, cellular uptake and cytotoxicity were assessed in 4T1 breast cancer cells. Gene expression analysis was performed, and in vivo antitumor efficacy was evaluated in 4T1 murine xenograft model with histopathological examination.
Results
The formulation achieved superior encapsulation efficiency of 70%, with DLS analysis revealing micelles having mean diameter of 30–40 nm (polydispersity index: 0.234) and zeta potential of –1.9 mV. TEM confirmed spherical morphology. FTIR validated structural integrity with characteristic peaks. In vitro release demonstrated burst release of 52.4±2.5% (6 hours) followed by sustained release reaching 85.9±2.5% (48 hours). Flow cytometry showed 13.75-fold increased cellular uptake (15.4% vs 1.12% FL4-H+cells). MTT assay revealed dose-dependent cytotoxicity. qRT-PCR demonstrated significant upregulation of apoptotic markers: Caspase-8 (2.071-fold, 95% CI: 1.308–3.299, P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Biomedical Engineering, College of Future Technology, Peking University, Beijing, China.
- Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Beijing, China.
ORCID-Profile: Aqeel Akab Sarhan, Ismaeil Haririan
Zitieren
APA
Sarhan, A. A., Haririan, I., Akrami, M., Saadatnia, F., & Ge, Z. (2026). Enhanced anticancer efficacy of α-lipoic acid-loaded TPGS micelles: Synthesis, characterization, and evaluation in a 4T1 breast cancer model. BioImpacts, 16, 31242. https://doi.org/10.34172/bi.31242
Vancouver
Sarhan AA, Haririan I, Akrami M, Saadatnia F, Ge Z. Enhanced anticancer efficacy of α-lipoic acid-loaded TPGS micelles: Synthesis, characterization, and evaluation in a 4T1 breast cancer model. BioImpacts. 2026;16:31242. doi:10.34172/bi.31242
BibTeX
@article{Sarhan2026,
author = {Sarhan, Aqeel Akab and Haririan, Ismaeil and Akrami, Mohammad and Saadatnia, Fatemeh and Ge, Zigang},
title = {Enhanced anticancer efficacy of α-lipoic acid-loaded TPGS micelles: Synthesis, characterization, and evaluation in a 4T1 breast cancer model},
journal = {BioImpacts},
year = {2026},
volume = {16},
pages = {31242},
doi = {10.34172/bi.31242}
}
EUVIMED